Fusion Antibodies’ quality policy is to achieve sustained profitable growth by the innovative production of recombinant proteins and antibodies, which consistently satisfy the needs and expectations of its customers. Through this we aim to become a recognised market leader for the supply of quality recombinant proteins and antibodies for both research and development of therapeutics. This level of quality is achieved through adoption of a system of procedures that reflect the competence of the company to existing customers, potential customers, and independent auditing authorities.

The Board, management and staff are committed to the implementation of the quality system as laid out the company’s Quality Manual. They are also committed to achieving set objectives, organisational goals and expectations and to meet the needs of Fusion Antibodies customers.

Achievement of quality involves all staff, who are individually responsible for the quality of their work. We will provide an environment in which every person is motivated to continually improve the efficiency and effectiveness of our products, processes and our management system.